Ser367
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser367  -  SMAD4 (mouse)

Site Information
RFCLGQLsNVHRTEA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1877718910

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
CD8+ (T lymphocyte) ( 1 ) , HEK293T (epithelial) ( 1 )

Upstream Regulation
Regulatory protein:
MEK1 (human) ( 1 )
Putative in vivo kinases:
ERK2 (human) ( 1 )
Kinases, in vitro:
ERK2 (human) ( 1 )
Treatments:
antibody ( 1 ) , SCH772984 ( 1 )

Downstream Regulation
Effects of modification on SMAD4:
intracellular localization ( 1 )
Effects of modification on biological processes:
carcinogenesis, inhibited ( 1 )

References 

1

Liu X, et al. (2022) SMAD4, activated by the TCR-triggered MEK/ERK signaling pathway, critically regulates CD8 T cell cytotoxic function. Sci Adv 8, eabo4577
35895826   Curated Info